nach oben

Archives of Osteoporosis

Erschienen in:

01.12.2023 | Original Article

The correlation between circulating growth differentiation factor 11 and the risk of osteopenia/osteoporosis in men

verfasst von: Miaomiao Jin, Renjun Cao, Pengfei Shan, Xiaohong Niu

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Summary

Our results suggest that the serum GDF11 concentration is significantly associated with the risk of bone metabolism dysfunction in men and may be a useful target for prediction of osteopenia/osteoporosis to enable prompt intervention for this common but invariably under- or misdiagnosed condition in men.

Purpose

Male osteopenia/osteoporosis remains a neglected subject or is under- or misdiagnosed. Many studies have confirmed the role of growth differentiation factor 11 (GDF11) in bone metabolism, although its role in bone metabolism remains controversial. In this study, we aimed to investigate the association between serum GDF11 levels and the prevalence of osteopenia/osteoporosis (OP) in a male cohort and explore the possibility of GDF11 to be a useful target for prediction of osteopenia/osteoporosis to enable prompt intervention for this disease.

Methods

This cross-sectional study included 121 native Chinese men randomly aged 20–87 years, excluded the subjects who had the conditions of bone metabolism-related disease and administration of hormonal drugs, and grouped the subjects to OP and non-OP, based on the WHO definition and latest guidelines of OP. The serum GDF11 concentration was determined using a GDF11-specific immunoassay. Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry. Tartrate-resistant acid phosphatase 5b (TRAP-5b) were measured in serum samples with ELISA method.

Results

We observed a negative correlation between serum GDF11 levels and age, a positive correlation between serum GDF11 levels and the femoral neck BMD, and a negative correlation between serum GDF11 levels and TRAP-5b in men. The prevalence and risk of OP were significantly higher in men with low serum GDF11 levels.

Conclusions

The serum GDF11 concentration is significantly associated with the risk of bone metabolism dysfunction and may be a useful target for prediction of OP in male cohort.

Anam AK, Insogna K (2021) Update on osteoporosis screening and management. Med Clin North Am 105(6):1117–1134. https://doi.org/10.1016/j.mcna.2021.05.016 CrossRefPubMed

Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (London, England) 353(9156):878–882. https://doi.org/10.1016/s0140-6736(98)09075-8 CrossRefPubMed

Haentjens P, Magaziner J, Colón-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152(6):380–390. https://doi.org/10.7326/0003-4819-152-6-201003160-00008 CrossRefPubMedPubMedCentral

Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet (London, England) 359(9319):1761–1767. https://doi.org/10.1016/s0140-6736(02)08657-9 CrossRefPubMed

Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 30(4):637–646. https://doi.org/10.1002/jbmr.2393 CrossRefPubMed

Porcelli T, Maffezzoni F, Pezzaioli LC, Delbarba A, Cappelli C, Ferlin A (2020) MANAGEMENT OF ENDOCRINE DISEASE: Male osteoporosis: diagnosis and management - should the treatment and the target be the same as for female osteoporosis? Eur J Endocrinol 183(3):R75–r93. https://doi.org/10.1530/eje-20-0034 CrossRefPubMed

Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie H et al (2013) miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res 28(5):1180–1190. https://doi.org/10.1002/jbmr.1845 CrossRefPubMed

Chen C, Cheng P, Xie H, Zhou HD, Wu XP, Liao EY et al (2014) MiR-503 regulates osteoclastogenesis via targeting RANK. J Bone Miner Res 29(2):338–347. https://doi.org/10.1002/jbmr.2032 CrossRefPubMed

Zhang Y, Shao J, Wang Z, Yang T, Liu S, Liu Y et al (2015) Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma. Gene 557(2):209–214. https://doi.org/10.1016/j.gene.2014.12.039 CrossRefPubMed

10.

Li Z, Zeng F, Mitchell AD, Kim YS, Wu Z, Yang J (2011) Transgenic overexpression of bone morphogenetic protein 11 propeptide in skeleton enhances bone formation. Biochem Biophys Res Commun 416(3-4):289–292. https://doi.org/10.1016/j.bbrc.2011.11.019 CrossRefPubMedPubMedCentral

11.

Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE et al (2015) GDF11 Increases with age and inhibits skeletal muscle regeneration. Cell Metab 22(1):164–174. https://doi.org/10.1016/j.cmet.2015.05.010 CrossRefPubMedPubMedCentral

12.

Suh J, Kim NK, Lee SH, Eom JH, Lee Y, Park JC et al (2020) GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone. Proc Natl Acad Sci U S A 117(9):4910–4920. https://doi.org/10.1073/pnas.1916034117 CrossRefPubMedPubMedCentral

13.

Jin M, Song S, Guo L, Jiang T, Lin ZY (2016) Increased serum GDF11 concentration is associated with a high prevalence of osteoporosis in elderly native Chinese women. Clin Exp Pharmacol Physiol 43(11):1145–1147. https://doi.org/10.1111/1440-1681.12651 CrossRefPubMed

14.

Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141. https://doi.org/10.1002/jbmr.5650090802 CrossRefPubMed

15.

Qaseem A, Forciea MA, McLean RM, Denberg TD, Barry MJ, Cooke M et al (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med 166(11):818–839. https://doi.org/10.7326/m15-1361 CrossRefPubMed

16.

Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P et al (2013) Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153(4):828–839. https://doi.org/10.1016/j.cell.2013.04.015 CrossRefPubMedPubMedCentral

17.

Hu Z, Yang K, Hu Z, Li M, Wei H, Tang Z et al (2021) Determining the association between hypertension and bone metabolism markers in osteoporotic patients. Medicine 100(24):e26276. https://doi.org/10.1097/md.0000000000026276 CrossRefPubMedPubMedCentral

18.

Opstad TB, Kalstad AA, Pettersen A, Arnesen H, Seljeflot I (2019) Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease. Exp Gerontol 119:53–60. https://doi.org/10.1016/j.exger.2019.01.020 CrossRefPubMed

19.

Lu B, Zhong J, Pan J, Yuan X, Ren M, Jiang L et al (2019) Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice. J Transl Med 17(1):422. https://doi.org/10.1186/s12967-019-02166-1 CrossRefPubMedPubMedCentral

20.

Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S (2010) Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res 25(5):983–993. https://doi.org/10.1359/jbmr.091104 CrossRefPubMed

21.

Khakpour S, Esrafilian A, Tanska P, Mononen ME, Korhonen RK, Jämsä T (2022) Effect of osteoporosis-related reduction in the mechanical properties of bone on the acetabular fracture during a sideways fall: a parametric finite element approach. PLoS One 17(2):e0263458. https://doi.org/10.1371/journal.pone.0263458 CrossRefPubMedPubMedCentral

22.

Doi M, Chiba K, Okazaki N, Kondo C, Yamada S, Yokota K et al (2022) Bone microstructure in healthy men measured by HR-pQCT: age-related changes and their relationships with DXA parameters and biochemical markers. Bone 154:116252. https://doi.org/10.1016/j.bone.2021.116252 CrossRefPubMed

23.

Zhou Y, Song L, Ni S, Zhang Y, Zhang S (2019) Administration of rGDF11 retards the aging process in male mice via action of anti-oxidant system. Biogerontology 20(4):433–443. https://doi.org/10.1007/s10522-019-09799-1 CrossRefPubMed

24.

Añón-Hidalgo J, Catalán V, Rodríguez A, Ramírez B, Silva C, Galofré JC et al (2019) Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes. Aging 11(6):1733–1744. https://doi.org/10.18632/aging.101865 CrossRefPubMedPubMedCentral

25.

Bin Z, Yanli Y, Zhen Q, Qingtao M, Zhongyuan X (2020) GDF11 ameliorated myocardial ischemia reperfusion injury by antioxidant stress and up-regulating autophagy in STZ-induced type 1 diabetic rats. Acta Cir Bras 34(11):e201901106. https://doi.org/10.1590/s0102-865020190110000006 CrossRefPubMedPubMedCentral

26.

Xu B, Huang Y, Zhang R, Tang M, He Z, Jin L et al (2021) Serum growth differentiation factor 11 is closely related to metabolic syndrome in a Chinese cohort. J Diabetes Investig 12(2):234–243. https://doi.org/10.1111/jdi.13337 CrossRefPubMed

Titel: The correlation between circulating growth differentiation factor 11 and the risk of osteopenia/osteoporosis in men
verfasst von: Miaomiao Jin
Renjun Cao
Pengfei Shan
Xiaohong Niu
Publikationsdatum: 01.12.2023
Verlag: Springer London
Erschienen in: Archives of Osteoporosis / Ausgabe 1/2023
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-023-01237-7

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, DICOM-Daten, Videos und Abbildungen. » Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

21.09.2023 | DGRh 2023 | Kongressbericht | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Impuls - Die Nachhaltigkeitsinitiative von Springer Medizin

Springer Medizin

The correlation between circulating growth differentiation factor 11 and the risk of osteopenia/osteoporosis in men

Abstract

Summary

Purpose

Methods

Results

Conclusions

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Medikamenteninduzierte Zytopenien bei Rheuma: Kennen Sie RILON?

Mobiles CT im Wiesn-Stresstest

Plantarfasziitis: viele Maßnahmen, wenig Evidenz

Plattfüße sind vielleicht gar nicht so platt

Update Orthopädie und Unfallchirurgie

Impuls - Die Nachhaltigkeitsinitiative von Springer Medizin

Springer Medizin

Abstract

Summary

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study

A clinical prediction model for 10-year risk of self-reported osteoporosis diagnosis in pre- and perimenopausal women

Association between exercise and risk of fractures in new-onset type 2 diabetes: a retrospective cohort study

LRP5 high bone mass (Worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature

Hip structural analysis, trabecular bone score, and bone mineral density in post-menopausal women with type-2 diabetes mellitus: a multi-center cross-sectional study in the south of Iran

Global prevalence of osteosarcopenic obesity amongst middle aged and older adults: a systematic review and meta-analysis

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Medikamenteninduzierte Zytopenien bei Rheuma: Kennen Sie RILON?

Mobiles CT im Wiesn-Stresstest

Plantarfasziitis: viele Maßnahmen, wenig Evidenz

Plattfüße sind vielleicht gar nicht so platt

Update Orthopädie und Unfallchirurgie